{
    "eid": "2-s2.0-85026527246",
    "title": "Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs",
    "cover-date": "2018-01-03",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Biological Psychiatry",
            "@code": "2803",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Anxiety",
        "Depression",
        "Immune",
        "Indoleamine 2,3-dioxygenase",
        "Inflammation",
        "Kynurenine",
        "Schizophrenia"
    ],
    "authors": [
        "Buranee Kanchanatawan",
        "Sunee Sirivichayakul",
        "Andr\u00e9 F. Carvalho",
        "George Anderson",
        "Piotr Galecki",
        "Michael Maes"
    ],
    "citedby-count": 14,
    "ref-count": 79,
    "ref-list": [
        "Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: role of the amygdala in developmental co-ordination",
        "How immune-inflammatory processes link CNS and psychiatric disorders: classification and treatment implications",
        "The interactions of tryptophan and its catabolites with melatonin and the alpha 7 nicotinic receptor in CNS and psychiatric disorders: role for the aryl hydrocarbon receptor and direct mitochondria regulation",
        "Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways",
        "Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome",
        "Bipolar disorder: The role of the kynurenine and melatonergic pathways",
        "Negative v positive schizophrenia. Definition and validation",
        "Effects of various kynurenine metabolites on respiratory parameters of rat brain, liver and heart mitochondria",
        "Kynurenine pathway in psychosis: evidence of increased tryptophan degradation",
        "A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality",
        "Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors",
        "Psychological and behavioural effects of interferons",
        "Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system",
        "Intrathecal immunoglobulin synthesis in MS - A complete reappraisal",
        "The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages",
        "Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons",
        "Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries",
        "A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis",
        "Circulating antibodies to IDO/THO pathway metabolites in Alzheimer's disease",
        "Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder",
        "Xanthurenic acid activates mGlu2/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia",
        "Gut microbiota interacts with brain microstructure and function",
        "The possible role of the kynurenine pathway in adolescent depression with melancholic features",
        "A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression",
        "The assessment of anxiety states by rating",
        "A rating scale for depression",
        "The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstr\u00f6m tolerance questionnaire",
        "The clinical significance of an elevated excretion of xanthurenic acid in psychiatric patients",
        "Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid",
        "Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift toward defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation",
        "Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition",
        "Negative symptom rating scale: limitations in psychometric and research methodology",
        "Evaluation of the factor structure of symptoms in patients with schizophrenia",
        "The schedule for the deficit syndrome: an instrument for research in schizophrenia",
        "Secondary negative symptoms - a review of mechanisms, assessment and treatment",
        "Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain",
        "The Validity of the Mini International Neuropsychiatric Interview (M.I.N.I.)",
        "Impact of different antipsychotics on cytokines and tryptophan metabolites in stimulated cultures from patients with schizophrenia",
        "A systematic review of instruments to measure depressive symptoms in patients with schizophrenia",
        "Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: focus on individual differences",
        "Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration",
        "Negative symptoms in schizophrenia: relationship to positive symptoms and outcome",
        "Psychopathology of schizophrenia: initial validation of a 5-factor model",
        "Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia",
        "Quinolinic acid: an endogenous neurotoxin with multiple targets",
        "Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review",
        "Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway",
        "Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression",
        "Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine",
        "Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers",
        "Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression",
        "Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation",
        "Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins",
        "The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation",
        "Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity",
        "The new \u20325-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression",
        "Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways",
        "Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression",
        "Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans",
        "Methodological problems in identifying and measuring first-rank symptoms of schizophrenia",
        "Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia",
        "The many neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders",
        "Effects of depression on the cytokine profile in drug na\u00efve first-episode psychosis",
        "Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic na\u00efve first episode psychosis",
        "Kynurenine and tryptophan levels in patients with schizophrenia with elevated ANTIGLIADIN immunoglobulin G antibodies",
        "Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder",
        "Are anxiety disorders associated with accelerated aging? A focus on neuroprogression",
        "IgA/IgM responses to Gram-negative bacteria are not associated with prenatal depression, but with physio-somatic symptoms and activation of the tryptophan catabolite pathway at the end of term and postnatal anxiety",
        "IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome",
        "Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge",
        "Increased cortical kynurenate content in schizophrenia",
        "Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation",
        "Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia\u2014significance for activation of the kynurenine pathway",
        "The macrophage-T-lymphocyte theory of schizophrenia: additional evidence",
        "Regulation of the immune response by natural IgM: lessons from warm autoimmune hemolytic anemia",
        "Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity",
        "Factor structure and external validity of the PANSS revisited",
        "Immunoglobulin G, A, and M\u2014clonal restriction in multiple sclerosis cerebrospinal fluid and serum\u2014analysis by two-dimensional electrophoresis",
        "A rating scale for mania: reliability, validity and sensitivity"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Londrina",
            "@id": "60027866",
            "affilname": "Universidade Estadual de Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027866",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Fortaleza",
            "@id": "60020457",
            "affilname": "Universidade Federal do Cear\u00e1",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020457",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Lodz",
            "@id": "60006651",
            "affilname": "Medical University of Lodz",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006651",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Waalre",
            "@id": "116324567",
            "affilname": "Revitalis",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116324567",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "London",
            "@id": "114423726",
            "affilname": "CRC Scotland &amp; London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114423726",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": [
        "Chulalongkorn University Centenary Academic Development Project",
        "Asahi Glass Foundation",
        "Chulalongkorn University"
    ]
}